English | Español

Regulatory
+ Regulatory
Press release submission | Jan 25, 2019

CENTERLINE BIOMEDICAL, INC.: Announces FDA Submission for IOPS System
+ Regulatory
Press release submission | Jan 16, 2019

JANSSEN: Announces European Commission approval of ERLEADA®(apalutamide) for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
+ Technology/Innovation
Press release submission | Jan 16, 2019

U.S. FOOD AND DRUG ADMINISTRATION: FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
+ Technology/Innovation
Press release submission | Jan 12, 2019

NATIONAL KIDNEY FOUNDATION: A Path Forward for Increasing Kidney Transplantation
+ Technology/Innovation
Press release submission | Jan 12, 2019

NYU LANGONE: New Analytic Model to Better Identify Patients Likely to Develop PTSD
+ Technology/Innovation
John Breslin | Jan 12, 2019

Inhaled insulin can be boon to diabetes sufferers, says JDRF
+ Regulatory
Press release submission | Jan 5, 2019

EPIZYME, INC.: Announces Registration Path for Tazemetostat for Follicular Lymphoma and Provides Pipeline Updates and 2019 Guidance
+ Technology/Innovation
Press release submission | Jan 5, 2019

RIBON THERAPEUTICS: Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation